Pfizer first expected vaccine wouldn’t be approved in Canada until February
OTTAWA — The president of Pfizer Canada says when the company signed a purchase agreement last August it didn’t expect its COVID-19 vaccine to get approved here until February.
Cole Pinnow also told the House of Commons health committee on Monday that changes to the dosing schedule and conflicting advice could make more people more hesitant to get the vaccine.
Last week, the National Advisory Committee on Immunization, or NACI, recommended delaying the second dose of all COVID-19 vaccines from three or four weeks after the first shot, to four months. The expert panel said real-world data on one dose shows it is highly effective and more people could get vaccinated with one dose sooner while vaccines are in short supply.
One of the reasons for that limited amount, said Pinnow, is because when the federal government signed a contract on Aug. 1 to get the vaccine, it believed Health Canada would not approve the vaccine until well after the New Year. The United Kingdom and United States saw a chance to get the vaccine authorized before Christmas and planned their deliveries accordingly, he said.


